EFFECT OF AGING AND OBESITY RELATED TESTOSTERONE DECLINE ON SERUM ADIPONECTIN LEVELS OF HEALTHY MALES
DOI:
https://doi.org/10.69656/pjp.v20i4.1689Keywords:
aging, obesity, testosterone, adiponectin, body mass index, waist hip ratio, waist circumference, BMI, WHRAbstract
Background: Men experience testosterone decline with both aging obesity which leads to enhanced adiponectin levels. Methods: It was a cross-sectional study that consisted of 80 healthy males who were equally divided into younger (20–40 years) and elder (41–60 years) categories, each was further divided equally into non-obese and obese groups. Serum testosterone and adiponectin levels were analyzed via Enzyme Linked Immunosorbent Assay (ELISA). Results: Testosterone levels of younger non-obese/obese males were significantly higher as compared to elder non-obese/obese males (p=0.00 and p=0.00) while testosterone levels of younger non obese participants were significantly higher than their obese counterparts (p=0.003). Adiponectin levels, however, of younger non obese participants were significantly lower than their elder non-obese and younger obese counterparts (p=0.001 and p=0.008 respectively). Moreover, elder non-obese and obese participants showed significant negative correlation between testosterone and adiponectin levels [(p=0.00) and (p=0.01)]. Also, younger and elder (regardless of obesity) and non-obese/obese participants (regardless of age) showed a significant negative correlation between serum testosterone and serum adiponectin levels [(p=0.00), (p=0.00), (p=0.00) and (p=0.00) respectively]. Conclusion: Testosterone levels decline with both aging and obesity, in otherwise healthy males, which makes adiponectin levels to rise. This in turn, though intricate physiological pathways, further deranges testosterone levels and thus puts aging and obese men at an increased risk of endo-metabolic disorders.
Pak J Physiol 2024;20(4):3?7, DOI: https://doi.org/10.69656/pjp.v20i4.1689
Downloads
References
Costa LBF, Rosa-E-Silva ACJS, Medeiros SF, Nacul AP, Carvalho BR, Benetti-Pinto CL, et al. Recommendations for the use of testosterone in male transgender. Rev Bras Ginecol Obstet 2018;40(5):275–80.
Bianchi VE, Locatelli V. Testosterone a key factor in gender related metabolic syndrome. Obes Rev 2018;19(4):557–75.
Motamer M, Javanmard SH, Mortazavi ZS, Bahrani S. Evaluation the effect of testosterone on the number of endothelial progenitor cells and amount of SDF-1?, PDGF, bFGF, and NO. Int J Prev Med 2019;10:214.
Groti K, Žuran I, Antoni? B, Foršnari? L, Pfeifer M. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. Aging Male 2018;21(3):158–69.
Bohlouli S, Khazaei M, Teshfam M, Hassanpour H. Adiponectin effect on the viability of human endometrial stromal cells and mRNA expression of adiponectin receptors. Int J Fertil Steril 2013;7(1):43–8.
Ishtiaq SM, Rashid H, Hussain Z, Arshad MI, Khan JA. Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease. Rev Endocr Metab Disord 2019;20(3):253–61.
Ahlstrom P, Rai E, Chakma S, Cho HH, Rengasamy P, Sweeney G. Adiponectin improves insulin sensitivity via activation of autophagic flux. J Mol Endocrinol 2017;59(4):339–50.
Sargolzaei J, Chamani E, Kazemi T, Fallah S, Soori H. The role of adiponectin and adipolin as anti-inflammatory adipokines in the formation of macrophage foam cells and their association with cardiovascular diseases. Clin Biochem 2018;54:1–0.
Dutta S, Sengupta P, Biswas A. Adiponectin in male reproduction and infertility. Asia Pac J Reprod 2019;8(5):244–50.
Holmboe SA, Skakkebæk NE, Juul A, Scheike T, Jensen TK, Linneberg A, et al. Individual testosterone decline and future mortality risk in men. Eur J Endocrinol 2018;178(1):121–8.
Rastrelli G, O'Neill TW, Ahern T, Bártfai G, Casanueva FF, Forti G, et al. Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: prospective results from the EMAS. Clin Endocrinol (Oxf) 2018;89(4):459–69.
Ng Tang Fui M, Hoermann R, Grossmann M. Effect of testosterone treatment on adipokines and gut hormones in obese men on a hypocaloric diet. J Endocr Soc 2017;1(4):302–12.
Moreau KL, Babcock MC, Hildreth KL. Sex differences in vascular aging in response to testosterone. Biol Sex Differ 2020;11(1):18.
Barone B, Napolitano L, Abate M, Cirillo L, Reccia P, Passaro F, et al. The Role of Testosterone in the Elderly: What Do We Know? Int J Mol Sci 2022;23(7):3535.
Xu X, Wang L, Luo D, Zhang M, Chen S, Wang Y, et al. Effect of testosterone synthesis and conversion on serum testosterone levels in obese men. Horm Metab Res 2018;50(9):661–70.
Wu A, Shi Z, Martin S, Vincent A, Heilbronn L, Wittert G. Age-related changes in estradiol and longitudinal associations with fat mass in men. PloS One 2018;13(8):e0201912.
Chosich J, Bradford AP, Allshouse AA, Reusch JE, Santoro N, Schauer IE. Acute recapitulation of the hyperinsulinemia and hyperlipidemia characteristic of metabolic syndrome suppresses gonadotropins. Obesity (Silver Spring) 2017;25(3):553–60.
Jarecki P, Herman WA, Pawliczak E, Lacka K. Can low SHBG serum concentration be a good early marker of male hypogonadism in metabolic syndrome?. Diabetes Metab Syndr Obes 2019;12:2181–91.
Sartorius G, Spasevska S, Idan A, Turner L, Forbes E, Zamojska A, et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self?reporting very good health: The healthy man study. Clin Endocrinol (Oxf) 2012;77(5):755–63.
Lanfranco F, Zitzmann M, Simoni M, Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (Oxf) 2004;60(4):500–7.
Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond) 2007;31(3):457–65.
Frederiksen L, Højlund K, Hougaard DM, Mosbech TH, Larsen R, Flyvbjerg A,et al. Testosterone therapy decreases subcutaneous fat and adiponectin in aging men. Eur J Endocrinol 2012;166(3):469–76.
Cui J, Wu X, Andrel J, Falskner B. Relationships of total adiponectin and molecular weight fractions of adiponectin with free testosterone in African men and premenopausal women. J Clin Hypertens (Greenwich) 2010;12(12):957–63.
Russell N, Grossmann M. Mechanisms in endocrinology: estradiol as a male hormone. Eur J Endocrinol 2019;181(1):R23–43.
Krause MP, Milne KJ, Hawke TJ. Adiponectin–Consideration for its role in skeletal muscle health. Int J Mol Sci 2019;20(7):1528.
Frühbeck G, Catalán V, Rodríguez A, Gómez-Ambrosi J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte 2018;7(1):57–62.
Han SJ, Boyko EJ, Fujimoto WY, Kahn SE, Leonetti DL. Low plasma adiponectin concentrations predict increases in visceral adiposity and insulin resistance. J Clin Endocrinol Metab 2017;102(12):4626–33.
Koleva DI, Orbetzova MM, Nikolova JG, Deneva TI. Pathophysiological role of adiponectin, leptin and asymmetric dimethylarginine in the process of atherosclerosis. Folia Med (Plovdiv) 2016;58(4):234–40.
Verdes G, Duta CC, Popescu R, Mituletu M, Ursoniu S, Fulger OL. Adiponectin mRNA and metabolic profile in malignant obesesity. Rev Chim (Bucharest). 2017;68(7):1501–5.
Palmer NO, Bakos HW, Fullston T, Lane M. Impact of obesity on male fertility, sperm function and molecular composition. Spermatogenesis 2012;2(4):253–63.
Bai J, Liu Y, Niu GF, Bai LX, Xu XY, Zhang GZ, et al. Relationship between adiponectin and testosterone in patients with type 2 diabetes. Biochem Med (Zagreb) 2011;21(1):65–70.
Emami A, Nazem MR, Hedayati M, Karami M. Four months of combined and compound morning training improves testosterone/cortisol ratio, adiponectin and insulin resistance in male students. Sport Sci Health 2016;12(2):215–20.
Elsaied MA, Masallat D, Abdel-Hamid IA. Correlation of adiponectin with testosterone in patients with and without type 2 diabetes and erectile dysfunction. Am J Men's Health 2019;13(1):1557988318807049.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, projected, cited and quoted with full reference of, and acknowledgement to the author(s) and the PJP. The contents are published with an international CC-BY-ND-4.0 License.
